Plain-English translation of NCT06585358 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new approach to TB treatment called Model-Informed Precision Dosing, which uses blood tests taken early in your treatment to help your doctor figure out the exact dose of TB medications that will work best for you. Instead of waiting weeks to adjust your dose based on standard guidelines, this method lets doctors personalize your medicine right from the start of treatment, when it matters most.
Many TB patients don't receive enough of their medications to fight the disease effectively, even though doctors follow standard dosing guidelines. This new approach aims to get patients on the right dose much faster—starting from day one—so they can have the best chance of recovery.
You likely qualify if…
You likely don't qualify if…
You would continue your standard TB treatment while the research team takes blood samples at specific times—particularly early in your treatment—to measure how your body is processing the TB medications. The study uses these blood test results along with mathematical models to help your doctor decide if your current dose is working well for you or if an adjustment might help. The study involves about 30 patients total and is being conducted at a medical center in Sweden.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Sweden